Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Biopath Automation L L C currently manages 1 pending office action within the Chemistry & Materials technology area. This single action is assigned to 1 distinct examiner and is being reviewed within 1 distinct art unit. This shows a focused prosecution profile, where the company's current activity is limited to a single technical matter and a single point of contact at the USPTO. The lack of diversity in examiners and art units simplifies the administrative overhead of tracking the company's intellectual property within Chemistry & Materials.
The busiest examiner for this portfolio is MUTREJA, JYOTI NAGPAUL, who is handling 1 pending office action. Because the total number of pending office actions is limited to this single matter, MUTREJA, JYOTI NAGPAUL is the only examiner currently reviewing the company's pending applications. This creates a singular focus for the applicant, as the success of the current prosecution depends entirely on the interactions and negotiations with this specific individual. Practitioners can focus their strategy on the specific examination practices and precedents of this examiner.
The presence of 1 distinct art unit indicates that the pending application falls within a specific technical category. For practitioners, this simplifies the management of the portfolio, as there are no competing examiner styles or differing art unit standards to consider. The prosecution strategy can be fully optimized for the specific requirements and practices of this unit, allowing for a concentrated effort on this single pending matter. This concentration of effort can lead to a more efficient path toward potential patent issuance for the company.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MUTREJA, JYOTI NAGPAUL | 1 | 81.1% | +4.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18229754 | SECTIONABLE CASSETTE AND EMBEDDING FRAME WITH TISSUE IMMOBILIZING SEPARABLE LID, AND METHODS FOR PREPARING BIOPSY TISSUE SAMPLES | MUTREJA, JYOTI NAGPAUL | — |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18229754 | SECTIONABLE CASSETTE AND EMBEDDING FRAME WITH TISSUE IMMOBILIZING SEPARABLE LID, AND METHODS FOR PREPARING BIOPSY TISSUE SAMPLES | MUTREJA, JYOTI NAGPAUL | 1798 | §102 | Non-Final OA | — | Pending | Aug 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiopath Automation L L C has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jyoti Nagpaul Mutreja has the most, with 1 of Biopath Automation L L C's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
